相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum
Christian Breymann et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
Morphological Assessment of Basic Multicellular Unit Resorption Parameters in Dogs Shows Additional Mechanisms of Bisphosphonate Effects on Bone
Matthew R. Allen et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation
Moez Gribaa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation
Emily G. Farrow et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide Another form of FGF23-related hypophosphatemia
Yuichiro Shimizu et al.
BONE (2009)
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Belinda J. Schouten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule
Emily G. Farrow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia
Belinda J. Schouten et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays
Brian H. Durham et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2007)
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Carole Peyssonnaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets
Erik A. Imel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis
Bettina Lorenz-Depiereux et al.
NATURE GENETICS (2006)
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Jian Q. Feng et al.
NATURE GENETICS (2006)
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Regulation of fibroblast growth factor-23 signaling by Klotho
H Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Iron loading into ferritin can be stimulated or inhibited by the presence of cations and anions: A specific role for phosphate
C Cutler et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed
T Larsson et al.
ENDOCRINOLOGY (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
Serum FGF23 levels in normal and disordered phosphorus homeostasis
TJ Weber et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Activation of the hypoxia-inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors
C Warnecke et al.
FASEB JOURNAL (2003)
Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death
BS Kim et al.
CELLULAR IMMUNOLOGY (2002)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Mutant FGF-23 responsible for autosomal dominant hypophosphatemic, rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo
T Shimada et al.
ENDOCRINOLOGY (2002)
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
KE White et al.
KIDNEY INTERNATIONAL (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The effects of dietary ferric iron and iron deprivation on the bacterial composition of the mouse intestine
GR Tompkins et al.
CURRENT MICROBIOLOGY (2001)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)